Agitation and Disinhibition After Frontal Lobe Injury
A 41-year-old woman is 6 weeks out from a severe traumatic brain injury with bifrontal contusions and a small subdural hematoma managed conservatively. She is now in inpatient rehabilitation. Staff report she is intermittently combative, uses profanity, and makes sexually inappropriate comments to male therapists. She has also begun eating constantly and has gained 4 kg in 3 weeks. Her family says she was previously a reserved schoolteacher. She sleeps only 3-4 hours per night and paces the halls. Mini-Mental State Examination score is 24/30, with errors in recall and attention. She is on no psychotropic medications. Blood pressure and heart rate are mildly elevated.
1. Formulate a differential for her behavioral syndrome and describe how you would distinguish the leading possibilities.
Read the worked answer
The syndrome combines disinhibition, apathy/impulsivity, hyperphagia, sleep disruption, and agitation - a frontal-lobe behavioral phenotype. Differential:
- Post-traumatic agitation/delirium: common early after severe TBI; should be considered if attention fluctuates. Her MMSE attention errors and pacing raise this possibility. Delirium usually has an identifiable trigger (infection, medication, metabolic derangement, seizures).
- Frontal lobe syndrome (dysexecutive/disinhibited variant): bifrontal contusions fit; hyperphagia, sexual disinhibition, and poor social judgment are classic.
- Hypothalamic injury: hyperphagia and sleep disruption suggest involvement of the ventromedial hypothalamus or its connections; consider MRI and endocrine screening.
- Manic or hypomanic episode: elevated mood, decreased need for sleep, pressured speech, and hypersexuality could represent secondary mania; requires collateral history and mood assessment.
- Seizure activity: nonconvulsive or complex partial seizures can present as episodic agitation; EEG is indicated if episodes are stereotyped or fluctuating.
- Substance withdrawal or medication effect: she is on no psychotropics, but review all agents.
Distinguish by: serial cognitive/attention testing, EEG, basic labs including sodium, glucose, and thyroid function, medication review, and collateral behavioral observation. Note that the MMSE is insensitive to executive dysfunction; a formal executive battery (e.g., verbal fluency, trail-making, clock drawing) is more informative.
2. What nonpharmacologic and pharmacologic strategies would you prioritize, and what monitoring is required?
Read the worked answer
Nonpharmacologic first: structured routine, low-stimulation environment, redirection, behavioral contracts, staff training for consistent responses, sleep hygiene, and safe outlets for pacing. Family involvement and education about the injury are essential. Address hyperphagia with scheduled meals and limits on access to food.
Pharmacologic: treat the target symptom, not the label.
- For disinhibition/impulsivity and agitation, consider a mood stabilizer such as valproate or carbamazepine, or an atypical antipsychotic at low dose for short-term behavioral control.
- Avoid benzodiazepines where possible - they can worsen confusion, disinhibition, and falls.
- If secondary mania is suspected, a mood stabilizer is first-line; antipsychotics may be added cautiously.
- Treat sleep disruption with sleep hygiene first; melatonin or trazodone may be considered; avoid sedating agents that worsen cognition.
Monitoring: track agitation with a validated scale (e.g., Agitated Behavior Scale), monitor weight and metabolic labs, check liver function and drug levels for valproate, watch for QT prolongation with antipsychotics, and reassess cognition serially. Re-evaluate for delirium triggers and obtain EEG if episodes are paroxysmal. Antipsychotics should be time-limited and reassessed because of metabolic and extrapyramidal risks.